000 01351cam a2200361 4500
020 _a924259346X
035 _a(Sirsi) i924259346X
060 _aQV 256 2005SU-1
242 0 0 _aSusceptibility of Plasmodium falciparum to antimalarial drugs :
_breport on global monitoring 1996-2004.
245 0 0 _aSensibilité de Plasmodium falciparum aux médicaments antipaludiques :
_brapport sur la surveillance globale 1996-2004.
260 _aGenève :
_bOrganisation mondiale de la Santé,
_c2005.
500 _aPrepared by Pascal Ringwald with the collaboration of Laura Shallcross, John Miller and Eric Seiber.
300 _aix, 135 p.
546 _aeng fre.
550 _aWHODOC
561 _aWHO monograph.
562 _aWHO/MAL/2005.1103.
650 0 2 _aAntimalarials
_xpharmacology.
650 0 2 _aPlasmodium falciparum
_xdrug effects.
650 0 2 _aMalaria, Falciparum
_xdrug therapy.
650 0 2 _aDrug resistance.
650 0 2 _aTreatment outcome.
690 _aParasitic Diseases and their Control.
700 1 _aRingwald, Pascal.
700 1 _aShallcross, Laura.
700 1 _aMiller, John Mark.
700 1 _aSeiber, Eric.
710 2 _aWorld Health Organization.
_bRoll Back Malaria Dept.
856 _uhttps://apps.who.int/iris/
008 050923s2005 sz 1 0 fre
596 _a4
942 _2NLM
_cMONOGRAPH
999 _c29790
_d29790